Skip to main content
. 2019 Jul 17;2019(7):CD004307. doi: 10.1002/14651858.CD004307.pub6

NCT02506829.

Trial name or title Financial Incentives for Smoking Treatment (FIESTA)
Methods Parallel‐assignment randomised controlled trial
Participants 182 urban veteran smokers
Interventions Financial incentives intervention: "Usual care in hospital, referral to a smoking cessation Quitline on discharge from hospital. Financial incentives for: a) speaking with a coach from the Smoker's Quitline ($50), b) completion of another community‐based smoking‐cessation program ($50), and/or c) use of pharmacotherapies for smoking cessation at 2 weeks ($50); and d) for smoking cessation, confirmed with the use of a cotinine test at 2 months ($150); and e) for smoking cessation, confirmed with the use of a cotinine test at 6 months after study enrollment ($250)."
Control: "Usual care in hospital, referral to a smoking cessation Quitline on discharge from hospital."
Outcomes Primary: Self‐report and biochemically verified (by salivary cotinine) smoking abstinence at 6 months
Secondary: Self‐report smoking abstinence at 6 months; use of evidence‐based treatments; quality of life (measured with EQ5‐D); short‐ and long‐term return on investment (cost analysis)
Starting date July 2015
Contact information Dr Joseph Ladapo JLadapo@mednet.ucla.edu
Dr Scott Sherman Scott.Sherman@nyumc.org
Notes